Effects of smooth muscle calcium antagonists on human basophil histamine release.
D001491:Basophils / Q000502:physiology*; D002118:Calcium / Q000037:antagonists & inhibitors*; D003620:Dantrolene / Q000494:pharmacology; D005707:Gallic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D005711:Gallopamil / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000502:physiology; D009543:Nifedipine / Q000494:pharmacology; D011794:Quercetin / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D005711:Gallopamil; C006014:8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate; D005707:Gallic Acid; D011794:Quercetin; D014700:Verapamil; D003620:Dantrolene; D009543:Nifedipine; D002118:Calcium